Results 241 to 250 of about 41,794 (337)

Novel pharmacological strategies for antiarrhythmic therapy in atrial fibrillation [PDF]

, 2011
Zsófia Kohajda, Zsófia Kohajda, Kristóf Attila, Attila Kristóf, Claudia Corici, Claudia Corici, László Virág, László Virág, DM Muntean, M. Muntean Danina, András Varró, András Varró, Norbert Jost, J Laszlo   +13 more
openalex  

Arrhythmogenic Mechanisms of Novel Biomarkers in Cardiac Electrophysiology

Cardiology Research and Practice, Volume 2026, Issue 1, 2026.
Arrhythmia is an important cause of cardiovascular disease deaths and a serious threat to human health, but the current means of identification are limited. Biomarkers, with the advantages of easy access and rapid detection, have shown significant value in arrhythmia risk prediction, precision diagnosis, and prognosis assessment.
Jin Liu, Huijie Guo, Yanmin Liu, Jinchun Wu, Irfan Ahmad   +4 more
wiley   +1 more source

Breaking the Rhythm: Extracorporeal Membrane Oxygenation (ECMO) as a Life Saver in a Case of Resistant Arrhythmia and Cardiac Arrest. [PDF]

Cureus
Fadl AB, Fadl A, Nadeem R.
europepmc   +1 more source

Impact of Nonhormonal Therapy for Climacteric Syndrome on the Efficacy of Antiarrhythmic Drugs in Women with Paroxysmal Atrial Fibrillation

R.F. Rakhmatullov
openalex   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 15 No. 1 [PDF]

, 1979

core   +1 more source

Animal Models and Treatment of Pulmonary Fibrosis: Pharmacogenetic and Nonpharmacogenetic

International Journal of Clinical Practice, Volume 2026, Issue 1, 2026.
Pulmonary fibrosis is a significant lung injury caused by multiple factors that profoundly affect the human quality of life. Currently, various animal models are used to understand the aetiology of pulmonary fibrosis and develop treatments. However, only pharmacogenetic models of pulmonary fibrosis have been discussed, and there have been no reviews of
Xingyu Fang, Haonan Bai, Zhanhong Cao, Dianyu Li, Yu An, Xiaohui Zhao, Nan Chen, Suraiya Saleem   +7 more
wiley   +1 more source

Catheter ablation vs antiarrhythmic drugs for persistent atrial fibrillation in hypertrophic cardiomyopathy. [PDF]

Heart Rhythm O2
Shahrori Z, Rayyan A, Sharma S, Sallam L, Arruda M, Mackall J, Sharma E.   +6 more
europepmc   +1 more source

Pursuit of Optimal Vagal Maneuvers in Stable Supraventricular Tachycardia: A Network Meta-Analysis. [PDF]

West J Emerg Med
Immanuel SS, Gotama JE, Sayogo Y, Sunjaya A, Tandecxi G, Anthony CP, Wirawan SA, Wibawa K, Suciadi LP.   +8 more
europepmc   +1 more source

Efficacy of modified versus standard Valsalva maneuvers on clinical outcomes and satisfaction of children with paroxysmal supraventricular tachycardia: randomized control trial. [PDF]

BMC Pediatr
Magor NRE, Elhalafawy SEH, Ads SEM, Abdelfattah ME, Melika SWM.   +4 more
europepmc   +1 more source

Antiarrhythmic Effect of Reverse Ventricular Remodeling Induced by Cardiac Resynchronization Therapy

, 2008
Luigi Di Biase, Maurizio Gasparini, Maurizio Lunati, Massimo Santini, Maurizio Landolina, Giuseppe Boriani, Antonio Curnis, Mario Bocchiardo, Antonio Vincenti, Alessandra Denaro, Sergio Valsecchi, Andrea Natale, Luigi Padeletti   +12 more
openalex   +2 more sources